◼ Archived
Business
🔮 fades
FDA reverses course on Regenxbio’s childhood gene therapy after rejection
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Regenxbio
2 trends tracked about this subject — the full history, oldest to newest below.
◼ Archived
Business
🔮 fades
Exclusive | FDA Gives Third Rare-Disease Drug Another Shot, Regenxbio Says
The FDA is allowing Regenxbio to resubmit its gene therapy for Hunter syndrome, marking a reversal of a previous rejection.